Table 2.
Nasal NK/T-cell lymphoma. Mexican population.
| Stage I-II No (% ) |
Stage III-IV No (% ) |
|
|---|---|---|
| Number | 1129 (75) | 395 (25) |
| Age (years): median Range |
50.1 | 46.8 |
| 22–64 | 27–60 | |
| Male | 601(53) | 198 (44) |
| IPI: Low-Low-intermediate | 989 (87) | 149 (37) |
| IPI: High-intermediate/High | 140 (12) | 246 (62) |
| Performance status (ECOG) <2 | 1004 (88) | 188 (47) |
| Performance status (ECOG) >2 | 125 (11) | 207 (52) |
| Bulky disease ( nasal site) cm.>10 |
301 (21) | 67 (16) |
| Bone Marrow infiltration | 0 | 127 (36) |
| Korean Prognostic Classification 0 | 608 (53) | 26 (6) |
| Korean Prognostic Classification 1 | 414 (36) | 84 (21) |
| Korean Prognostic Classification 2 | 89 (8) | 110 (27) |
| Korean Prognostic Classification 3 | 8 (07) | 175 (44) |